Phase 1/2 Findings Highlight RGX-202’s Safety, Impact on Key Duchenne Biomarkers
[ad_1] NeurologyLive® originally published this article. This version has been lightly edited.ad Aravindhan Veerapandiyan, MD Image Credit: Arkansas Children’s Hospital Recently, additional findings from the ongoing phase 1/2 AFFINITY DUCHENNE…